HOME >> MEDICINE >> NEWS
Papillomavirus vaccine could substantially reduce cervical cancer incidence

Administering Human Papillomavirus Vaccine (HPV) to both sexually active women and those who have never had sex could substantially reduce the incidence of HPV related cervical cancer and precancers, conclude authors of an Article published in this week's edition of the Lancet.

Cervical cancer is the second leading cause of death from cancer in women worldwide, and is caused by infection with oncogenic (cancer causing) types of human papillomavirus. Around 500,000 new cases are diagnosed each year, 80% in developing countries, resulting in 250,000 deaths.

Dr Kevin Ault, Emory University School of Medicine, Atlanta, Georgia, USA and colleagues from around the world formed the Future II Study Group to investigate the efficacy of the vaccine.

For women who have never had sex, the vaccine was 99% effective in stopping cervical cancer (adenocarcinoma in situ), and pre-cancerous lesions.

When data from women who could have been exposed was included, the vaccine efficacy was 44%.

The researchers enrolled over 20,000 women aged 15-26 from the Americas, Europe and Asia-Pacific in the study. Some 9,000 of these were given the full vaccine; around 1,200 were given a component of the vaccine and the rest a placebo.

The women involved were recruited at university student health centres, urban clinics, advertisements and by word of mouth. Healthy women who were not pregnant, had no report of a previous abnormal pap smear, and had a lifetime history of less than four to five sex partners were eligible.

The authors say that further follow-up of large trials will be needed to establish how long the vaccine remains effective.

They conclude: "The results of this quadrivalent HPV vaccine programme provide strong evidence that implementation of HPV vaccination campaigns in pre-adolescent girls and young adult women will reduce rates of cervical cancer worldwide."

In an accompanying comment, Dr Maur
'"/>

Contact: Juliette Merchant
juliette.merchant@emory.edu
404-778-1503
Lancet
31-May-2007


Page: 1 2

Related medicine news :

1. Papillomavirus vaccine could reduce rate of vulval and vaginal cancers
2. Traditional Chinese exercises may increase efficacy of flu vaccine
3. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
4. Study reveals gaps in vaccine financing for underinsured children
5. Trials underway for essential new TB vaccine
6. Hib vaccine: A critical ally in Asias effort to reduce child deaths
7. Progress toward an antitumor vaccine
8. Chemotherapy may enhance the effectiveness of brain tumor vaccines
9. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
10. International studies show high efficacy for HPV vaccine
11. Vaxfectin-formulated measles DNA vaccine elicits long-term protection in nonhuman primates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, ... the Top 54 RHIT Degree Programs for 2020. The comprehensive research guide is ... Each program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 ... cities offer them as public transit options. The article highlighted the life-changing or life-ending ... confined to a bed to a rider fatality after an incident with a vehicle. ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Insights Awards™, the only national awards dedicated to recognizing excellence in the areas ... awards were presented in nine different categories during the GlobeSt Healthcare Conference today ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... study of AZD4041 for treating tobacco use and dependence. The study will investigate ... nervous system (CNS) penetrant antagonist of orexin-1 (hypocretin-1) receptors that is being developed ...
(Date:12/2/2019)... ... ... Interim HealthCare Inc. , a national franchisor of home care, hospice ... . Selected for its multi-pronged approach to building a strong workforce, Interim HealthCare’s commitment ... By 2025, the U.S. will need to hire 2.5 million new healthcare workers to ...
Breaking Medicine News(10 mins):
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... ... owner of A Mission for Michael, an intensive mental health facility, announced it ... to oversee client relations, business development and national advocacy efforts. , "We are ...
(Date:12/2/2019)... ... December 02, 2019 , ... Smile ... dental groups in the United States, today announced the grand opening of another ... , Patients will enjoy convenient hours, a comfortable office and full-service care ...
(Date:12/2/2019)... ... December 02, 2019 , ... Strong public health departments ... learn, and play. Striving to fulfill their crucial mission, more and more health ... by the Public Health Accreditation Board (PHAB). Today, PHAB announced it has awarded ...
Breaking Medicine Technology:
Cached News: